EZR and esophageal squamous cell carcinoma: To explore the effect of ezrin on PALM2-mediated ESCC cell migration, ezrin knockout KYSE450 cells were constructed using CRISPR/Cas9 technology, and two monoclonal cell lines were successfully obtained (Fig. 6A).